Loading...
Revasum, Inc.
RVS.AX•ASX
Technology
Semiconductors
A$0.12
A$0.00(0.00%)

Over the last four quarters, Revasum, Inc.'s revenue moved from $5.74M in Q3 2022 to $7.16M in Q2 2023. Operating income in Q2 2023 was -$2.44M, with a strong operating margin of -34%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Revasum, Inc. remained robust at -$2.05M, reflecting operational efficiency. Net income dropped to -$2.73M, with an EPS of -$0.03. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan